NanoMosaic

About:

NanoMosaic provides solutions for early illness detection, prognostic monitoring, and biomarker identification.

Website: https://www.nanomosaicllc.com/

Top Investors: RA Capital Management, Insight Partners, Pura Vida Investments, TIME BioVentures, TigerGene

Description:

NanoMosaic provides solutions for early illness detection, prognostic monitoring, and biomarker identification. Its protein interrogation powered by nanoneedles enables early disease detection, prognostic monitoring, and biomarker discovery on a single chip. .

Total Funding Amount:

$40.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Woburn, Massachusetts, United States

Founded Date:

2018-01-01

Contact Email:

info(AT)nanomosaicllc.com

Founders:

John Boyce, Qimin Quan

Number of Employees:

11-50

Last Funding Date:

2021-12-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai